Frequently discordant results from therapeutic drug monitoring for digoxin: Clinical confusion for the prescriber

Internal Medicine Journal

Volumn 40, Issue 1, 2010, Pages 52-56

  Rogers, N M ^a   Jones, T E ^a   Morris, R G ^b,c  

^a Department of Nephrology and Transplantation Services ^*

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Digoxin; Mortality; Therapeutic drug monitoring

Indexed keywords

DIGOXIN;

ARTICLE; AUSTRALIA; CONFUSION; DRUG MONITORING; HUMAN; IMMUNOASSAY; LABORATORY; PATIENT CARE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; TOXICITY;

CARDIOVASCULAR DISEASES; CLINICAL LABORATORY TECHNIQUES; DIGOXIN; DRUG MONITORING; HUMANS; PATHOLOGY, CLINICAL; PHYSICIAN'S ROLE; TREATMENT OUTCOME;

EID: 76749087521     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01847.x     Document Type: Article

References (18)

1. Hussain Z, Swindle J, Hauptman P. Digoxin use and digoxin toxicity in the post-DIG trial era. J Card Fail 2006 12 : 343 346.
2. Duhme D, Greenblatt D, Koch-Weser J. Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program. Ann Intern Med 1974 80 : 516 519.
3. Gheorghiade M, Adams K, Colucci W. Digoxin in the management of cardiovascular disorders. Circulation 2004 109 : 2959 2964.
4. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 336 : 525 533.
5. Ahmed A, Gambassi G, Weaver M, Young J, Wehrmacher W, Rich M. Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure. Am J Cardiol 2007 100 : 280 284.
6. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003 289 : 871 878. (Pubitemid 37430346)
7. Valdes RJ. Endogenous digoxin-immunoreactive substance measured in several patient populations. Prog Clin Biol Res 1985 192 : 221 228.
8. Morris R, Frewin D, Saccoia N, Goldsworthy W, Jeffries W, McPhee A. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods. Eur J Clin Pharmacol 1990 39 : 359 363.
9. Morris R, Lagnado P, Lehmann D, Frewin D, Glistak M, Burnett R. Spironolactone as a source of interference in commercial digoxin immunoassays. Ther Drug Monit 1987 9 : 208 211.
10. Steimer W, Muller C, Eber B. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids. Clin Chem 2002 48 : 507 516.
11. Dasgupta A, Wu S, Actor J, Olsen M, Well A, Datta P. Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs. Am J Clin Pathol 2003 119 : 298 303.
12. Adams JF, Lindenfield JA, Arnold JM, Baker D, Barnard DH, Baughman KL et al. Heart Failure Society of America (HFSA) 2006 comprehensive heart failure practice guidelines. J Card Fail 2006 12 : 10 36.
13. Adams KJ, Gheorghiade M, Uretsky B, Patterson J, Schwartz T, Young J. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 2002 39 : 946 953.
14. Smellies W, Coleman J. Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin. BMJ 2007 334 : 312 315.
15. Gheorghiade M, van Veldhuisen D, Colucci W. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation 2006 113 : 2556 2564.
16. Kurata Y, Ieiri I, Kimura M, Morita T, Irie S, Urae A et al. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther 2002 72 : 209 219.
17. Ahmed A, Rich M, Love T, Lloyd-Jones D, Inmaculada B, Colucci W et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006 27 : 178 186.
18. Dasgupta A, Saldana S, Heimann P. Monitoring free digoxin instead of total digoxin in patients with congestive cardiac failure and high concentrations of digoxin-like immunoreactive substances. Clin Chem 1990 36 : 2121 2123.